Next generation drug manufacturing
Next generation drug manufacturing
Next generation drug manufacturing Next generation drug manufacturingnanodrug prototyping
Next generation drugs require a new approach
Whether you're improving traditional chemotherapeutics, modifying lipids, evolving antibodies, or looking for a way to deliver CRISPR, PNAs or RNA, the ability to create a batch of finished drug particles in your own lab significantly shortens cycle times.
A new lab tool
Smaller research groups are the new vanguard of drug design. The idea is simple: next gen drugs are multicomponent, and each little molecular piece needs to be created by an expert with very specific capabilities. An expanding community of next gen drug developers will share improved drug components as they become available.
How it works
Like most other nanoparticle building approaches, a flow solvent and buffer are combined to allow for particle self assembly. However, Synvir has created a novel form of microfluidic channels that leverage a computer control system to ensure the delivery of precisely sized particles that match your dimensional specification. Just inject your reagents and press "Go".